ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 1, 2010, Pages 245-250

  Doherty, Jennifer A ^a   Rossing, Mary Anne ^a   Cushing Haugen, Kara L ^a   Chen, Chu ^a   Van Den Berg, David J ^b   Wu, Anna H ^b   Pike, Malcolm C ^b   Ness, Roberta B ^c   Moysich, Kirsten ^d   Chenevix Trench, Georgia ^e   Beesley, Jonathan ^e   Webb, Penelope M ^e   Chang Claude, Jenny ^f   Wang Gohrke, Shan ^g   Goodman, Marc T ^h   Lurie, Galina ^h   Thompson, Pamela J ^h   Carney, Michael E ^h   Hogdall, Estrid ⁱ   Kjaer, Susanne Kruger ⁱ   Hogdall, Claus ^j   Goode, Ellen L ^k   Cunningham, Julie M ^k   Fridley, Brooke L ^k   Vierkant, Robert A ^k   Berchuck, Andrew ^l   Moorman, Patricia G ^m   Schildkraut, Joellen M ^m   Palmieri, Rachel T ⁿ   Cramer, Daniel W ^o   Terry, Kathryn L ^o   Yang, Hannah P ^p   Garcia Closas, Montserrat ^p   Chanock, Stephen ^p   Lissowska, Jolanta ^q   Song, Honglin ^r   Pharoah, Paul D P ^r   Shah, Mitul ^r   Perkins, Barbara ^r   McGuire, Valerie ^s   Whittemore, Alice S ^s   Di Cioccio, Richard A ^d   Gentry Maharaj, Aleksandra ^t   Menon, Usha ^t   Gayther, Simon A ^t   Ramus, Susan J ^t   Ziogas, Argyrios ^u   Brewster, Wendy ^u   Anton Culver, Hoda ^a   Pearce, Celeste Leigh ^b   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF ULM   (Germany)

^h UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁱ INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^j Rigshospitalet   (Denmark)

^k Mayo Clinic   (United States)

^l Div of Gen Obstet and Gynecology   (United States)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁿ IL   (United States)

^o BRIGHAM AND WOMEN S HOSPITAL   (United States)

^p NATIONAL CANCER INSTITUTE   (United States)

^q INSTITUTE OF ONCOLOGY   (Poland)

^r UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^s STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY COLLEGE LONDON   (United Kingdom)

^u UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CELL FUNCTION; CONTROLLED STUDY; CYTOKINESIS; DOWN REGULATION; ESTROGEN RECEPTOR ALPHA 1 GENE; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; GOLGI COMPLEX; HUMAN; OVARY CANCER; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTRIN REPEAT CONTAINING NUCLEAR ENVELOPE 1; UNITED STATES;

ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 74549167142     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0729     Document Type: Article

References (15)

1. Fan J, Beck KA. A role for the spectrin superfamily member Syne-1 and kinesin II in cytokinesis. J Cell Sci 2004;117:619-29.
2. Zhang Q, Skepper JN, Yang F, et al. Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci 2001;114:4485-98.
3. Gough LL, Fan J, Chu S, Winnick S, Beck KA. Golgi localization of Syne-1. Mol Biol Cell 2003;14:2410-24.
4. Marme A, Zimmermann HP, Moldenhauer G, et al. Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas. Int J Cancer 2008;123:2048-56.
5. Pearce CL, Near AM, Van Den Berg DJ, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 2009;100:412-20.
6. Song H, Ramus SJ, Kjaer SK, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 2009;18:2297-304.
7. Ramus SJ, Vierkant RA, Johnatty SE, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 2008;123:380-8.
8. Zheng W, Long J, Gao YT, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009;41:324-8.
9. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812-4.
10. Gros-Louis F, Dupre N, Dion P, et al. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat Genet 2007;39:80-5.
11. Zhang Q, Bethmann C, Worth NF, et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 2007;16:2816-33.
12. Tessema M, Willink R, Do K, et al. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res 2008;68:1707-14.
13. Schuebel KE, Chen W, Cope L, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007;3:1709-23.
14. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314:268-74.
15. Jordan SJ, Green AC, Whiteman DC, Webb PM. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum? Gynecol Oncol 2007;107: 223-30.